NOVARTINDBSENovartis India Ltd· Pharmaceuticals & BiotechnologyHighNeutral
Announced Tue, 23 Jun, 2026 · 18:58 IST

Novartis India Open Offer sees minimal tendering as of June 23

Open Offer TriggeredListed Co AcquisitionStrategic Transactions View source PDFExplain this filing

NOVARTIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.0%Reaction day
₹1474.90
prior close
₹1480.20
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.1%+0.1% vs market
Pharmaceuticals peers, median of 164sector-0.0%+0.0% vs sector

On the reaction day the stock moved 0.1 pts more than Nifty Microcap 250 and in line with its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+1.0
10m
+2.4
15m
+1.4
30m
+0.9
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.0-0.1+0.1-0.0+0.0
Next day
-3.0-0.7-2.3-0.8-2.2
2d
-2.0-1.0-1.0+0.0-2.1
3d
-3.0+0.0-3.1+0.4-3.4
4d
-1.7+0.2-1.9+0.4-2.1
5d
-1.0+1.1-2.1+0.3-1.4
1w
-1.6+0.9-2.5+0.7-2.3
15d
+8.3+0.8+7.5+1.1+7.1
1m
+11.9-0.8+12.7-0.6+12.5
2m
+1.0+5.0-4.0+1.5-0.5
3m
+33.5+5.0+28.5+4.9+28.6
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Axis Capital, manager to the Novartis India open offer, disclosed tendering status as of June 23, 2026. The offer is for up to 64.196 lakh equity shares (26 percent of voting capital) at face value INR 5, by WaveRise Investments, ChrysCapital Fund X, and Two Infinity Partners. Only 112 physical shares have been tendered so far, with zero demat shares, totaling about 0.00 percent of the offer size.

Likely market impact

Very low early tendering suggests public shareholders may be waiting for more clarity or better terms; offer remains open.